作者
Viviana Maestrini, Lucia Ilaria Birtolo, Marco Francone, Gioacchino Galardo, Nicola Galea, Paolo Severino, Francesco Alessandri, Maria Chiara Colaiacomo, Giulia Cundari, Cristina Chimenti, Carlo Lavalle, Maria Ciardi, Paolo Palange, Alberto Deales, Gabriella d'Ettorre, Claudio M Mastroianni, Carlo Catalano, Franco Ruberto, Francesco Pugliese, Giulia d'Amati, Francesco Fedele, Massimo Mancone, Albante Alida, Araimo Morselli Fabio, Auricchio Daniela, Letizia D'Antoni, Barletta Giovanna, Bilotta Federico, Brisciani Matteo, Bruno Katia, Bucarelli Maria Clelia, Cappannoli Alessandro, Ceccarelli Giancarlo, Celli Paola, Consolo Stella, Consoli Giulia, Croce Claudia, Crocitti Beatrice, Francavilla Santi, Giannetti Lorena, Giordano Giovanni, Ianni Stefano, Imperiale Carmela, Maestrini Ilaria, Magnanimi Eugenia, Manganelli Chiara, Maldarelli Federica, Martelli Sabina, Messina Teresa, Novelli Martina, Pasculli Patrizia, Pasqualitto Fabiola, Pattelli Elisa, Pecorari Filippo, Perrella Serena, Petroianni Angelo, Piazzolla Mario, Portieri Monica, Prosperi Silvia, Rachele Edoardo Sebastian, Ratini Fabiola, Ricci Claudia, Romano Hilde, Sabani Anna, Santopietro Pietro, Tellan Guglielmo, Titi Luca, Tordiglione Paolo, Tosi Antonella, Trigilia Fausto, Verduci Noemi, Vaccaro Paola
发表日期
2021/9/15
期刊
International journal of cardiology
卷号
339
页码范围
235-242
出版商
Elsevier
简介
Background
Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up.
Methods
Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard electrocardiogram (ECG), Troponin and echocardiography were integrated by further tests when indicated. Medical history, arterial blood gas, blood tests, chest computed tomography and treatment were recorded. CVD was defined as the occurrence of a new condition during the hospitalization for COVID-19. Survivors attended a one-month follow-up visit and a one-year telephone …
引用总数
学术搜索中的文章